Stopping JIA Drugs? Many Can Regain Control After a Flare
About 67% of patients who stopped medications for well-controlled JIA got their condition under control by 1 year after a flare occurred, according to registry-based research findings.
Stay updated with breaking news from Grant Schulert. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
About 67% of patients who stopped medications for well-controlled JIA got their condition under control by 1 year after a flare occurred, according to registry-based research findings.
Six days after the Supreme Court struck down the right to abortion, lupus patient Becky Schwarz got an unexpected message from her rheumatologist.
Among consequences to the end of Roe vs. Wade: Rheumatology patients lose access to a crucial drug. Why? It can be used to end ectopic pregnancies.
What you need to know about MIS-C, the post-COVID sickness affecting kids In most cases, the risk of hospitalization and death from COVID-19 increases alongside the patientâs age. But a small number of children who recover from COVID-19 face a new threat in the weeks afterward: Multisystem inflammatory syndrome (MIS-C), which can end in death. and last updated 2021-04-14 18:13:09-04 CINCINNATI â In most cases, the risk of hospitalization and death from COVID-19 increases alongside the patientâs age. People over the age of 80 are more likely than any other group to die of the il...
MIS-C cases on the rise in children with at least 3,000 reported and 36 dead As schools around the country continue to reopen with full backing of the Biden administration, the Centers for Disease Control and Prevention (CDC), and the unwavering support of the unions, doctors have begun reporting a frightening trend: a concerning uptick in the number of MIS-C cases among children and adolescents. MIS-C, or Multisystem Inflammatory Syndrome, is on the rise among children. It is an acute medical condition observed in children who have either been diagnosed with COVID-19, or who were in close co...